Cart
sales@molnova.com
Home - Products - Angiogenesis - CDK - JNJ-7706621

JNJ-7706621

CAS No. 443797-96-4

JNJ-7706621( JNJ7706621 | JNJ 7706621 )

Catalog No. M14517 CAS No. 443797-96-4

A dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 86 In Stock
5MG 102 In Stock
10MG 158 In Stock
25MG 282 In Stock
50MG 445 In Stock
100MG 616 In Stock
200MG 861 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    JNJ-7706621
  • Note
    Research use only, not for human use.
  • Brief Description
    A dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM).
  • Description
    A dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM), and no activity for Plk1 or Wee1; arrests the cell cycle at the G2-M phase; shows significant antitumor activity in tumor xenograft model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    JNJ7706621 | JNJ 7706621
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    AuroraA|AuroraB|CDK1/CyclinB|CDK2/CyclinA|CDK2/CyclinE
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    443797-96-4
  • Formula Weight
    394.356
  • Molecular Formula
    C15H12F2N6O3S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=S(C1=CC=C(NC2=NN(C(C3=C(F)C=CC=C3F)=O)C(N)=N2)C=C1)(N)=O
  • Chemical Name
    Benzenesulfonamide, 4-[[5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Emanuel S, et al. Cancer Res. 2005 Oct 1;65(19):9038-46. 2. Huang S, et al. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3639-41. 3. Seamon JA, et al. Mol Cancer Ther. 2006 Oct;5(10):2459-67.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • SB1317 hydrochloride

    SB1317 is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).

  • CGP-74514A hydrochlo...

    CGP-74514A hydrochloride is a potent CDK1 inhibitor with IC50 of 25 nM; induces caspase-9 activation and PARP degradation, mediates apoptosis in U937 cells.

  • PCI-27483

    PCI 27483 is an activated coagulation factor VIIa inhibitor with antithrombotic effects in a baboon model of arterial thrombosis.

Sign In Join Free